Terms: = Thyroid cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Treatment
20 results:
1. Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.
Morand GB; Tessler I; Noik M; Krasner J; Yamin T; Pusztaszeri MP; Avior G; Payne RJ
Endocr Pract; 2024 Apr; 30(4):319-326. PubMed ID: 38184241
[TBL] [Abstract] [Full Text] [Related]
2. Global research trends and prospects related to tumor microenvironment within Triple Negative Breast cancer: a bibliometric analysis.
Li P; Li J; Tong X; Xiao Z; Diao W; Zhong C; Zhou J; Wu W
Front Immunol; 2023; 14():1261290. PubMed ID: 38111580
[TBL] [Abstract] [Full Text] [Related]
3. Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk thyroid cancer Patients.
Biondi B; Pucci M; Pontieri G; Formisano P; Esposito R
Thyroid; 2023 Dec; 33(12):1402-1413. PubMed ID: 37725587
[No Abstract] [Full Text] [Related]
4. A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.
Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
Cancer Lett; 2023 Feb; 555():216049. PubMed ID: 36608865
[TBL] [Abstract] [Full Text] [Related]
5. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
Pray BA; Youssef Y; Alinari L
Exp Hematol; 2022 Dec; 116():18-25. PubMed ID: 36206873
[TBL] [Abstract] [Full Text] [Related]
6. False Negative Rates in Benign thyroid Nodule Diagnosis: Machine Learning for Detecting Malignancy.
Idarraga AJ; Luong G; Hsiao V; Schneider DF
J Surg Res; 2021 Dec; 268():562-569. PubMed ID: 34464894
[TBL] [Abstract] [Full Text] [Related]
7. Vascular interventions in head and neck cancer patients as a marker of poor survival.
Krol E; Brandt CT; Blakeslee-Carter J; Ahanchi SS; Dexter DJ; Karakla D; Panneton JM
J Vasc Surg; 2019 Jan; 69(1):181-189. PubMed ID: 30579444
[TBL] [Abstract] [Full Text] [Related]
8. Staff and ambient radiation dose resulting from therapeutic nuclear medicine procedures.
Alkhorayef M; Sulieman A; Mohamed-Ahmed M; Al-Mohammed HI; Alkhomashi N; Sam AK; Bradley DA
Appl Radiat Isot; 2018 Nov; 141():270-274. PubMed ID: 30145016
[TBL] [Abstract] [Full Text] [Related]
9. Temporal Trends in treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of secondary and primary thyroid cancer in adolescents and young adults.
Goldfarb M; Freyer DR
Cancer; 2014 Apr; 120(8):1155-61. PubMed ID: 24615715
[TBL] [Abstract] [Full Text] [Related]
11. Increasing the size limit of benign thyroid lesions resectable by endoscopic thyroidectomy via a unilateral axillo-breast approach without gas insufflation.
Kim WS; Hong HJ; Shin YS; Choi EC; Choi HS; Koh YW
World J Surg; 2011 Oct; 35(10):2203-11. PubMed ID: 21853357
[TBL] [Abstract] [Full Text] [Related]
12. Routine bilateral central lymph node clearance for papillary thyroid cancer.
Sadowski BM; Snyder SK; Lairmore TC
Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Nakamura N; Nakamine H; Bessho M; Hirano M
Ann Oncol; 2007 Jul; 18(7):1203-8. PubMed ID: 17429099
[TBL] [Abstract] [Full Text] [Related]
14. The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.
Verkooijen RB; Smit JW; Romijn JA; Stokkel MP
Eur J Endocrinol; 2006 Dec; 155(6):801-6. PubMed ID: 17132748
[TBL] [Abstract] [Full Text] [Related]
15. [Dynamics of morbidity of the thyroid gland cancer. Evolution of views on its diagnosis and treatment (according to material of the clinic for 50 years)].
Cheren'ko MP; Mamonov OV
Klin Khir; 2001 Jun; (6):50-3. PubMed ID: 11688268
[TBL] [Abstract] [Full Text] [Related]
16. thyroid nodularity and cancer among Chernobyl cleanup workers from Estonia.
Inskip PD; Hartshorne MF; Tekkel M; Rahu M; Veidebaum T; Auvinen A; Crooks LA; Littlefield LG; McFee AF; Salomaa S; Makinen S; Tucker JD; Sorensen KJ; Bigbee WL; Boice JD
Radiat Res; 1997 Feb; 147(2):225-35. PubMed ID: 9008215
[TBL] [Abstract] [Full Text] [Related]
17. [Current treatment approaches and prospects in thyroid cancer].
Komissarenko IV; Rybakova SI; Kovalenko AE; Lysenko AG; Demchenko NP; Kvacheniuk AN
Lik Sprava; 1995; (9-12):23-6. PubMed ID: 8983780
[TBL] [Abstract] [Full Text] [Related]
18. [Surgical treatment of thyroid cancer].
Komissarenko IV; Rybakov SI; Kovalenko AE
Klin Khir (1962); 1993; (12):40-3. PubMed ID: 8046870
[TBL] [Abstract] [Full Text] [Related]
19. [Mass screening for breast cancer in Gunma prefecture--the results for 8 years and future problems].
Ishida T; Yokoe T; Ogawa T; Kurosumi M; Kurebayashi J; Yoshida M; Yamada I; Iino Y; Izuo M
Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2400-10. PubMed ID: 2614178
[TBL] [Abstract] [Full Text] [Related]
20. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.
Hay ID; Grant CS; Taylor WF; McConahey WM
Surgery; 1987 Dec; 102(6):1088-95. PubMed ID: 3686348
[TBL] [Abstract] [Full Text] [Related]
